Pregled bibliografske jedinice broj: 715315
β-1, 4-Galactosyltransferase 1 Expression Is Required for Platelet Production in Vitro and In Vivo.
β-1, 4-Galactosyltransferase 1 Expression Is Required for Platelet Production in Vitro and In Vivo. // Glycobiology
Seattle (WA), Sjedinjene Američke Države, 2011. str. 1515-1516 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 715315 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
β-1, 4-Galactosyltransferase 1 Expression Is Required for Platelet Production in Vitro and In Vivo.
Autori
Giannini, Silvia ; Grozovsky, Rrenata ; Jurak Begonja, Antonija, Hoffmeister, Karin M.
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Glycobiology
/ - , 2011, 1515-1516
Skup
Annual Conference of the Society for Glycobiology 1454
Mjesto i datum
Seattle (WA), Sjedinjene Američke Države, 09.11.2011. - 12.11.2011
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
surface glycoproteins; platelet production
Sažetak
Platelet turnover requires correct glycan presentation and expression. Deficiency in β-1, 4-galactosyltransferase 1 (β4GalT1), the major enzyme that transfers galactose (Gal) from UDP-Gal to terminal N-acetylglucosamine (GlcNAc) to form type-2 lactosaminyl structures, is lethal in embryonic mice. However, E14.5 β4GalT1−/- embryos are grossly indistinguishable from wild type embryos. Here we sought to determine whether platelet formation and survival require β4GalT1. Hepatic stem cells were obtained from embryonic livers at E14.5 and megakaryoctes were differentiated in vitro in the presence of thrombopoietin. β4GalT1−/- megakaryocytes mature and differentiate normally in vitro as judged by their number, morphology and expression of main surface glycoproteins specific for the megakaryocyte lineage (GPIbα/β, GPIX, αIIb and β3). However, following differentiation, β4GalT1−/- megakaryocytes were unable to produce proplatelets and platelets in vitro. Addition of exogenous β4GalT1 and the donor substrate UDP-Galactose did not improve in vitro proplatelet and platelet formation. Importantly, platelet numbers were decreased by 75% in β4GalT1−/- E14.5 embryos when compared to wild type embryos. Platelet size was increased by 50% in β4GalT1−/- embryos, indicating that β4GalT1−/- mice have increased platelet clearance and/or that larger platelets are produced in vivo. Our data strongly support the notion that glycosylation mediated by β4GalT1 activity is crucial for platelet production in vitro and in vivo. Our findings demonstrate for the first time a role for posttranslational glycan modification in platelet production.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
- MEDLINE